Are You Prepared for an OTC COVID-19 Test Audit?
Billing and dispensing OTC COVID-19 tests is widespread throughout community pharmacies.
Entries by Jennifer Ottman, CPhT
DMEPOS Mini-Series #6 – Therapeutic Shoes for Diabetes
Every 17 seconds someone is diagnosed. Noridian, Jurisdiction D, has been conducting Targeted Probe and Educate reviews of HCPCS code A5500, which is for therapeutic shoes.
DMEPOS Mini-Series #5 – Surgical Dressings
Use these helpful tips and links to be prepared in case of an audit on surgical dressings.
Trudhesa™ Nasal Spray for the Treatment of Migraines
Migraine relief medications are frequently monitored and flagged for audit due to high cost, quantities submitted, days’ supply and/or frequency of refills.
DMEPOS Mini-Series #4 – Urological Supplies: Intermittent Catheters
If you are a Medicare Part B supplier, then you are aware that billing Medicare B is quite different than billing other payors.
Metformin ER – Can I Substitute?
Many pharmacies struggle with identifying which metformin ER product they can dispense or substitute, explore the three different strengths …
DMEPOS Mini-Series #3 – Diabetic Test Strips
If you are a Medicare Part B supplier, then you have likely had an audit on diabetic test strips. Billing Medicare Part B is quite different than other payors, and consequently, can be very challenging for pharmacies.
When Should I Obtain a Diagnosis Code for Ozempic?
Since Ozempic® was FDA approved December 5, 2017, PAAS National® has fielded many questions regarding dispensing this expensive injectable diabetic medication.
DMEPOS Mini-Series #2 – Ostomy Supplies
PAAS National® often sees recoupments on ostomy supplies due to unsupported medical records.
Are Your Patients Running Out of Supplies for Their Continuous Glucose Monitor?
Pharmacies often struggle with audits for DMEPOS items. The Medicare Part B/DMEPOS billing model is a complex maze of units, codes and documentation requirements that are very different from billing traditional prescription drugs.
